Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination
Zachary Susswein, Eugenio Valdano, Tobias Brett, Pejman Rohani, View ORCID ProfileVittoria Colizza, Shweta Bansal
doi: https://doi.org/10.1101/2021.08.09.21261807
Zachary Susswein
1Georgetown University
Eugenio Valdano
2INSERM
Tobias Brett
3University of Georgia, Athens
Pejman Rohani
3University of Georgia, Athens
Vittoria Colizza
2INSERM
Shweta Bansal
1Georgetown University
Posted August 10, 2021.
Ignoring spatial heterogeneity in drivers of SARS-CoV-2 transmission in the US will impede sustained elimination
Zachary Susswein, Eugenio Valdano, Tobias Brett, Pejman Rohani, Vittoria Colizza, Shweta Bansal
medRxiv 2021.08.09.21261807; doi: https://doi.org/10.1101/2021.08.09.21261807
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12629)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4490)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2873)
- Health Policy (1059)
- Hematology (380)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4258)
- Nursing (228)
- Nutrition (625)
- Oncology (2229)
- Ophthalmology (636)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6842)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (377)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)